Edition:
United Kingdom

NantKwest Inc (NK.OQ)

NK.OQ on NASDAQ Stock Exchange Global Select Market

4.75USD
22 Feb 2018
Change (% chg)

$0.20 (+4.40%)
Prev Close
$4.55
Open
$4.62
Day's High
$5.00
Day's Low
$4.60
Volume
66,682
Avg. Vol
74,227
52-wk High
$8.43
52-wk Low
$2.71

Latest Key Developments (Source: Significant Developments)

Altor Bioscience and NantKwest announces co-development agreement
Tuesday, 4 Oct 2016 

NantKwest Inc: Financial terms of this co-development are not disclosed . Development agreement to advance innovative natural killer cell combination immunotherapies for the treatment of cancer . Altor and Co will exclusively collaborate on development of therapeutic applications combining altor's proprietary IL-15 superagonist .Altor, Co to also exclusively collaborate single-chain t cell receptor/IL-2 fusion protein products with Co's proprietary NK cell therapy platforms.  Full Article